The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The Pharma 4.0 Future Desired State is to be data-driven & capable of holistic process control with information available at the right time with content, quality, security and traceability. This Digital Maturity ensures patient safety & intended product performance. To get to this state, Pharma 4.0 defines enabling capabilities for systems in general, and connectivity in particular, to achieve vendor-agnostic “Plug and Produce”. This presentation covers the status and progress made in the Pharma 4.0 Plug & Produce workgroup on architecture, connectivity standards, current proof of concept projects and insights from Hackathons, including realized concept of a simplified vendor-agnostic integration of qualified laboratory devices with the Asset Administration Shell as the Digital Twin. Links to relevant ISPE publications, including new Pharma 4.0 concept papers, are provided. Bridging strategies for brown-field equipment and collaborations with other industry working groups e.g., NAMUR, BioPhorum Group, VdMA, SiLA, LADS are touched on as well.
Speaker(s):
Josef
TRAPL,
Head of MSci Innovation,
Takeda Pharmaceutical International AG
Mr. Jörn
VOLCKMANN,
Associated Director Manufactuing Excellence,
Frontwell Solutions GmbH
Mr. Wolfgang
WINTER,
Software Framework R&D Director,
Agilent Technologies Deutschland GmbH
Credits
Credits: None available.
You must be logged in and own this session in order to
post comments.